Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer

Fig. 5

Histological changes encountered after treatment with miR-92a-LNA-inhibitor in mice liver; a PBS group - liver architecture within normal limits; b LNA-i-miR-NC group - liver architecture within normal limits; c LNA-i-miR-92a group - intralobular necrosis of hepatocytes with scattered mononuclear inflammatory cells and signs of hepatocytes regeneration with binucleated cells present; slides stained with H + E × 400

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us